Via Scientific
Latest round
- Seed
Last raised
- Oct 2023
Total raised
- $4.5M
Investors
- 2
About Via Scientific
Founded in 2022 by James J. Crowley, and Janet Kosloff, and based in Massachusetts, US, Via Scientific, Inc. operates as an Integrated Bioinformatics Operating System that enables scientists and bioinformaticians to generate novel science. In January 2024, Via Scientific, Inc. Foundry offers products like vCloud, xCloud, xPrem, and vPro, catering to diverse computing environments, including public clouds and private clusters. The firm’s platform is designed to simplify enterprise-scale multi-omics and analytics, enabling scientists, computational biologists, and bioinformaticians to concentrate on their research rather than managing code and compute infrastructure.
Who invested in Via Scientific
2 investors across 1 round
See all investors in Via Scientific
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Oct 15, 2023
Amount
$4.5M
Investors
Questions about Via Scientific
Who invested in Via Scientific?
Via Scientific has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Via Scientific raised?
Via Scientific has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Via Scientific last raise money?
Via Scientific's most recent round on record is a Seed, in Oct 2023.
What does Via Scientific do?
Via Scientific is a healthcare it company.
Where is Via Scientific headquartered?
Via Scientific is headquartered in Cambridge, US.
Which VCs invest in companies like Via Scientific?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at Via Scientific's stage. Their profiles are linked below.
VCs backing healthcare it startups at Seed
Raising like Via Scientific? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.